law of increasing return

Digital

The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.

News

Belgian biotech UCB has made its second acquisition of the year, buying T-cell engager player Candid Therapeutics for up to $2.2 billion.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.